Table 1.
Experiment type | Animal type/cell type | Tumor type | US-sensitive vehicle | Immunostimulation materials | US parameter | Immune effect | Reference |
---|---|---|---|---|---|---|---|
In vivo | C57BL/6 mice | Melanoma | Microbubbles | Antigen and mRNA | 1 MHz, 2 W/cm2, 20% duty, 30 seconds insonation time | Tumor outgrowth ↓ | Dewitte et al50 |
In vivo | C57BL/6 mice | Melanoma | Liposome microbubbles | Antigens | 2 MHz, 2.0 W/cm2, 10% duty, 3×10 seconds insonation time | Melanoma lung metastases ↓ | Oda et al51 |
In vivo | C57BL/6 mice | Ovarian carcinoma | PEG-modified bubble lipoplexes | pDNA | Not mentioned | Antitumor effects ↑ | Un et al57 |
In vivo | C57BL/6 mice | Melanoma | Mannose-modified bubble lipoplexes | pDNA | 1.045 MHz, 1.0 W/cm2, 50% duty, 1 minute insonation time | Transcriptional factors ↑ | Yoshida et al59 |
In vitro | DLD1 and AGS cells | Colorectal cancer | Phase-change nanodroplets | Antibody | 100 cycles at 4 MHz, 1.5 MPa peak negative pressure | Tumor cell apoptosis ↑ | Ishijima et al64 |
In vivo | Nude rats | Brain metastasis | Microbubbles | Antibody | 0.40–0.70 W/cm2, 10 ms burst sonications, 0.46–0.62 MPa peak negative pressure | Tumor outgrowth ↓ | Kobus et al71 |
In vivo | Athymic nude rats | Breast cancers with HER2 | Definity microbubble | NK-92 | 551.5 kHz focused transducer, 0.33 MPa average peak rarefaction pressure | NK-92 brain delivery ↑ | Alkins et al82 |
In vitro | Tregs from HCC patients | Hepatocellular carcinoma | SonoVue microbubble | T cells | 10% microbubbles, 1.4 mechanical index, 150 or 180 seconds insonation time | Treg proliferation ↑ | Shi et al88 |
In vivo | C57BL/6 X C3H/He mice | Ovarian carcinoma | Bubble liposomes | pDNA | 1 MHz, 0.7 W/cm2, 60 seconds insonation time | Tumor outgrowth ↓ | Suzuki et al94 |
Notes: ↑, up regulated; ↓, down-regulated.
Abbreviations: HCC, hepatocellular carcinoma; NK, natural killer; PEG, poly(ethylene glycol); Treg, regulatory T cell; UMMD, ultrasound-mediated microbubble destruction; US, ultrasound.